Frank L. Douglas, Ph.D., M.D.

Frank L. Douglas, Ph.D., M.D., Chair, Governance Committee and Scientific Advisory Board

An award-winning industry veteran with more than three decades of experience in healthcare, pharmaceuticals, and entrepreneurship, Dr. Frank Douglas leads EOM’s clinical development team. He held leadership roles in both large and small biopharmaceutical companies, leading teams that were responsible for the development and marketing approval of many drugs, including Allegra®, Lantus®, Taxotere®, and Actone®.

Dr. Douglas has held several academic positions, including Professor of the Practice in the Massachusetts Institute of Technology (MIT) Sloan School of Management and similar appointments in the departments of Biology, Biological Engineering, and the Harvard-MIT Division of Health Sciences and Technology. He also was the founder and first executive director of the MIT Center for Biomedical Innovation and is the recipient of numerous prestigious awards, including being honored twice as the Global Pharmaceutical R&D Director of the Year.

Dr. Douglas holds a BS in Chemistry from Lehigh University, Ph.D. in Physical Chemistry, and a M.D. from Cornell University.